• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 9Studies showing some relationship between rejection and method of MPA monitoring. Limited sampling strategies - 2h Post (C2)

StudyPopulationTreatmentMajor Findings/ Comments
Kiberd57 2004Organ transplanted: Kidney (Renal)Dose: 2 g/day fixedDay 3 MPA C2 significantly (p=0.025) predicted later rejection.
Study design: Case seriesAge: Mean 48 +/- 13yConcomitant medications:
Length of followup: 3 monthsPrednisone
Neoral

Abbreviations: MPA=Mycophenolic Acid, y=Years

From: 3, Results

Cover of Utility of Monitoring Mycophenolic Acid in Solid Organ Transplant Patients
Utility of Monitoring Mycophenolic Acid in Solid Organ Transplant Patients.
Evidence Reports/Technology Assessments, No. 164.
Oremus M, Zeidler J, Ensom MHH, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.